Using metformin to reduce knee pain after ACL surgery
Official title: Preventing Injured Knees From osteoArthritis: Severity Outcomes (PIKASO)
Run by Brigham and Women's Hospital · NCT06096259 · Data updated 2026-11-12
This study is testing if metformin can help reduce knee pain and prevent arthritis in people recovering from ACL surgery.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 512 (estimated) |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 9 sites (Atlanta, Georgia and 8 other locations) |
| Status | Recruiting |
| Started | May 6, 2024 |
| Main results expected | December 2029 |
| Study ends | December 2030 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT06096259 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 18-45 who plan to undergo ACL reconstruction within 12 months of their injury and have specific preoperative pain levels.
✕Probably not a fit
Patients with inflammatory arthritis, diabetes, or significant knee damage may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of metformin in reducing pain and delaying the onset of post-traumatic osteoarthritis (PTOA) following anterior cruciate ligament (ACL) reconstruction. Participants will be randomly assigned to receive either metformin or a placebo, which looks identical but contains no active medication. The study aims to determine if metformin's known anti-inflammatory properties can benefit individuals recovering from ACL injuries. By focusing on a specific age group and preoperative pain levels, the study seeks to identify those most likely to benefit from this intervention.
Why it matters
Potential benefit: If successful, this study could provide a new treatment option to reduce pain and improve outcomes for patients recovering from ACL injuries.
How similar studies have gone: While metformin is primarily known for diabetes management, its anti-inflammatory effects suggest potential benefits in similar contexts, though this specific application is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 25-45 or Age 18-24 with preoperative KOOS Pain \<80 (0-100, 100 best) recorded at least 14 days after the day of ACL injury 2. Plan to undergo ACL reconstruction within 12 months of injury Exclusion Criteria: 1. Inflammatory arthritis 2. Pregnancy and/or lactation, or plans to become pregnant in the next 12 months 3. Known contraindication to metformin 4. Current use of metformin or topiramate 5. Diabetes mellitus or diabetic ketoacidosis 6. Acute or chronic renal insufficiency 7. History of prior ACL tear on the index knee, with or without reconstruction 8. History of ACL tear on the contralateral knee within the past 12 months 9. Applying for or receiving Workers' Compensation for their knee injury 10. Joint space narrowing AND definite osteophyte(s) on weightbearing radiograph on index knee 11. Tibial plateau fracture on index knee 12. Concomitant avulsion fracture of index knee that will be treated surgically 13. Concomitant posterior cruciate ligament, medial collateral ligament, or lateral collateral ligament injury on index knee requiring surgical repair/reconstruction 14. Contraindication to MRI 15. Unable to speak and understand English 16. Diagnosis of cognitive impairment or otherwise unable to provide informed consent 17. Insufficient time for recruitment and drug titration: Surgery scheduled for \<14 days from the time of screening 18. Date of injury more than 6-months ago, relative to date of screening 19. Presence of a condition or abnormality that in the opinion of the surgeon investigator would compromise the safety of the patient or the quality of the data 20. Plan for allograft at time of consent
Where it's running
-
Emory University
Atlanta, Georgia, United States Recruiting -
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States Recruiting -
University of Kentucky
Lexington, Kentucky, United States Recruiting -
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting -
University of Nebraska Medical Center
Omaha, Nebraska, United States Recruiting -
Hospital for Special Surgery
New York, New York, United States Recruiting
Show 3 more locations
-
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States Recruiting -
Cleveland Clinic
Cleveland, Ohio, United States Recruiting -
The Ohio State University
Columbus, Ohio, United States Recruiting
Study contacts
- Principal investigator: Morgan H Jones, MD, MPH — Brigham and Women's Hospital
- Study coordinator: Faith Selzer, PhD
- Email: fselzer@bwh.harvard.edu
- Phone: 617-525-8617
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of Vibration on Knee Health After ACL Surgery
This study is testing if adding vibration therapy to regular rehab can help people recovering from ACL surgery have better knee health and lower the chance of future injuries.
-
SVF cellular mix, secretome, and knee response in osteoarthritis
This study tests the cellular composition and secretome of research-only adipose-derived SVF in adults with knee OA who are already planned to receive an autologous SVF injection as part of their care.
-
Effect of a Resistance Exercise Program on IGF-1 Levels in Knee Osteoarthritis
A structured 8-week resistance exercise program is being tested to see if it changes blood IGF-1 levels and improves knee OA symptoms in adults with knee OA and metabolic traits.
-
2-mm subchondral drilling vs sequential 4-mm and 2-mm drilling during CARTISTEM implantation for knee cartilage defects
This study tests whether drilling the knee with a 2-mm drill alone works as well as sequential 4-mm then 2-mm drilling when combined with CARTISTEM treatment for medial knee cartilage defects.
-
Undenatured Type II Collagen for Knee Osteoarthritis Pain (Three-Arm Trial)
This study tests whether taking undenatured type II collagen capsules once daily for 4 months can reduce knee pain in adults with knee osteoarthritis, compared with two collagen formulations and a placebo.
-
Serum Fetuin‑A and COMP levels in knee osteoarthritis
This study tests whether levels of Fetuin‑A and COMP in the blood relate to how severe knee osteoarthritis is in patients compared with healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.